Nu Skin Enterprises
6
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
17%
1 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Healthy Food Prescription Incentive Program
Role: collaborator
Research on Sleep and Emotion Testing of Tea Theanine Casein Hydrolysate Pressed Candy
Role: collaborator
Study on Carotenoid-Based Instrumental Index
Role: collaborator
Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women
Role: collaborator
Effects of a Nutritional Supplement Combination on Body Weight Management
Role: collaborator
Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer
Role: collaborator
All 6 trials loaded